These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24105080)

  • 1. Inhibition of olanzapine-induced weight gain by the retinoid analog AM-80.
    Richards M; Chiba S; Ninomiya M; Wakabayasi C; Kunugi H
    Pharmacopsychiatry; 2013 Nov; 46(7):267-73. PubMed ID: 24105080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.
    Cooper GD; Pickavance LC; Wilding JP; Harrold JA; Halford JC; Goudie AJ
    J Psychopharmacol; 2007 Jun; 21(4):405-13. PubMed ID: 17050655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
    Cooper GD; Harrold JA; Halford JC; Goudie AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance.
    Lykkegaard K; Larsen PJ; Vrang N; Bock C; Bock T; Knudsen LB
    Schizophr Res; 2008 Aug; 103(1-3):94-103. PubMed ID: 18579346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A parametric analysis of olanzapine-induced weight gain in female rats.
    Cooper GD; Pickavance LC; Wilding JP; Halford JC; Goudie AJ
    Psychopharmacology (Berl); 2005 Aug; 181(1):80-9. PubMed ID: 15778884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats.
    Fell MJ; Marshall KM; Williams J; Neill JC
    J Psychopharmacol; 2004 Jun; 18(2):149-55. PubMed ID: 15260902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.
    Deng C; Lian J; Pai N; Huang XF
    J Psychopharmacol; 2012 Sep; 26(9):1271-9. PubMed ID: 22695490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.
    Han M; Deng C; Burne TH; Newell KA; Huang XF
    Psychoneuroendocrinology; 2008 Jun; 33(5):569-80. PubMed ID: 18358632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
    Minet-Ringuet J; Even PC; Goubern M; Tomé D; de Beaurepaire R
    Appetite; 2006 May; 46(3):254-62. PubMed ID: 16551485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
    Fell MJ; Anjum N; Dickinson K; Marshall KM; Peltola LM; Vickers S; Cheetham S; Neill JC
    Psychopharmacology (Berl); 2007 Oct; 194(2):221-31. PubMed ID: 17581744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways.
    Lian J; Huang XF; Pai N; Deng C
    Psychoneuroendocrinology; 2014 Oct; 48():77-86. PubMed ID: 24992721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain.
    Patil BM; Kulkarni NM; Unger BS
    Eur J Pharmacol; 2006 Dec; 551(1-3):112-5. PubMed ID: 17046744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters.
    Davey KJ; O'Mahony SM; Schellekens H; O'Sullivan O; Bienenstock J; Cotter PD; Dinan TG; Cryan JF
    Psychopharmacology (Berl); 2012 May; 221(1):155-69. PubMed ID: 22234378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of thermogenesis in antipsychotic drug-induced weight gain.
    Stefanidis A; Verty AN; Allen AM; Owens NC; Cowley MA; Oldfield BJ
    Obesity (Silver Spring); 2009 Jan; 17(1):16-24. PubMed ID: 19107124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An animal model of antipsychotic-induced weight gain.
    Arjona AA; Zhang SX; Adamson B; Wurtman RJ
    Behav Brain Res; 2004 Jun; 152(1):121-7. PubMed ID: 15135975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats.
    Lazzari P; Serra V; Marcello S; Pira M; Mastinu A
    Eur Neuropsychopharmacol; 2017 Jul; 27(7):667-678. PubMed ID: 28377074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
    Raskind MA; Burke BL; Crites NJ; Tapp AM; Rasmussen DD
    Neuropsychopharmacology; 2007 Feb; 32(2):284-8. PubMed ID: 16710316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in rats.
    Belanoff JK; Blasey CM; Clark RD; Roe RL
    Eur J Pharmacol; 2011 Mar; 655(1-3):117-20. PubMed ID: 21269600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine-activated AMPK signaling in the dorsal vagal complex is attenuated by histamine H1 receptor agonist in female rats.
    He M; Zhang Q; Deng C; Wang H; Huang XF
    Endocrinology; 2014 Dec; 155(12):4895-904. PubMed ID: 25264935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia.
    Hosojima H; Togo T; Odawara T; Hasegawa K; Miura S; Kato Y; Kanai A; Kase A; Uchikado H; Hirayasu Y
    J Psychopharmacol; 2006 Jan; 20(1):75-9. PubMed ID: 16204328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.